AI assistant
CVS HEALTH Corp — Director's Dealing 2018
Nov 21, 2018
29875_dirs_2018-11-21_e1f4be90-935f-417a-a581-beb9ce82a62a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-11-19
Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8040.2554 | Direct |
| Common Stock (restricted) | 858 | Direct |
| Common Stock (restricted) | 537 | Direct |
| Common Stock (restricted) | 831 | Direct |
| Common Stock (restricted) | 2214 | Direct |
| Common Stock (restricted) | 274 | Direct |
| Common Stock (restricted) | 2009 | Direct |
| Common Stock (restricted) | 1057 | Direct |
| Common Stock (restricted) | 790 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $45.07 | 2019-04-02 | Common Stock (1664) | Direct | |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (3030) | Direct | |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (5350) | Direct | |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (6059) | Direct | |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (7044) | Direct | |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (9050) | Direct | |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (7513) | Direct |
Footnotes
F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020.
F2: Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments on 2/28/2019 and 2/28/2020.
F3: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019.
F4: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 2/28/2021.
F5: Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse 2/28/2019.
F6: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 4/1/2022.
F7: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021.
F8: Consists of Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/28/2019.
F9: Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013.
F10: Remaining Options became exercisable in four equal annual installments beginning on 4/1/2014.
F11: Remaining Options became exercisable in four equal annual installments beginning on 4/1/2015.
F12: Options became exercisable in four equal annual installments beginning on 4/1/2016.
F13: Options became exercisable in four equal annual installments beginning on 4/1/2017.
F14: Options became exercisable in four equal annual installments beginning on 4/3/2018.
F15: Options become exercisable in four equal annual installments, commencing 4/1/2019.